Getinge

Report Publication Announcement • Oct 4, 2012

Getinge announces date of 2012 Q3 report and conference call

GETINGE will issue its Q3 report for 2012 on Wednesday 17th of October 2012 at 12:00 CET, followed by a conference call at 15:00 CET, hosted by Johan Malmquist, CEO, and Ulf Grunander, CFO.

To participate in the conference, please dial: Swedish dial in number: +46 (0) 8 5876 9446 UK dial in number: +44 (0) 20 3106 4822 US dial in number: +1 646 254 3366 Participant passcode: 8164231

Agenda 14:45 Call in to the conference 15:00 Review of the Q3 report 15:20 Q&A 16:00 Close of the conference

A recorded version of the conference can be accessed for 5 working days on the following number: Sweden: +46 (0) 8 5051 3897 UK: +44 (0) 20 7111 1244 US: +1 347 366 9565 Code: 8164231

During the telephone conference a presentation will be held. To access the presentation, please use this link: http://www.livemeeting.com/cc/premconfeurope/join?id=8164231&role=attend&pw=pw5643

Alternatively enter the VisionCast site and log into your meeting using the Meeting ID and Password below: VisionCast: http://www.euvisioncast.com Your Name: (Enter your name) Web Meeting ID: 8164231 Web Meeting Password: pw5643

For more information, please contact: Kornelia Rasmussen Group Communications Phone: +46 (0)10 335 5810 E-mail: kornelia.rasmussen@getinge.com GETINGE GROUP is a leading global provider of products and systems that contribute to quality enhancement and cost efficiency within healthcare and life sciences. We operate under the three brands of ArjoHuntleigh, GETINGE and MAQUET. ArjoHuntleigh focuses on patient mobility and wound management solutions. GETINGE provides solutions for infection control within healthcare and contamination prevention within life sciences. MAQUET specializes in solutions, therapies and products for surgical interventions, interventional cardiology and intensive care.

The information is such that Getinge AB must disclose in accordance with the Swedish Securities Market Act and/or the Financial Instruments Trading Act.